Elsevier

Neuropharmacology

Volume 48, Issue 1, January 2005, Pages 161-172
Neuropharmacology

Phasic cardiovascular responses to mevinphos are mediated through differential activation of cGMP/PKG cascade and peroxynitrite via nitric oxide generated in the rat rostral ventrolateral medulla by NOS I and II isoforms

https://doi.org/10.1016/j.neuropharm.2004.08.012Get rights and content

Abstract

The organophosphate insecticide mevinphos (Mev) acts on the rostral ventrolateral medulla (RVLM), where sympathetic vasomotor tone originates, to elicit phasic cardiovascular responses via nitric oxide (NO) generated by NO synthase (NOS) I and II. We evaluated the contribution of soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) cascade and peroxynitrite in this process. PKG expression in ventrolateral medulla of Sprague–Dawley rats manifested an increase during the sympathoexcitatory phase (Phase I) of cardiovascular responses induced by microinjection of Mev bilaterally into the RVLM that was antagonized by co-administration of 7-nitroindazole or Nω-propyl-l-arginine, two selective NOS I inhibitors or 1-H-[1,2,4]oxadiaolo[4,3-a]quinoxalin-1-one (ODQ), a selective sGC antagonist. Co-microinjection of ODQ or two PKG inhibitors, KT5823 or Rp-8-Br-cGMPS, also blunted the Mev-elicited sympathoexcitatory effects. However, the increase in nitrotyrosine, a marker for peroxynitrite, and the sympathoinhibitory circulatory actions during Phase II Mev intoxication were antagonized by co-administration of S-methylisothiourea, a selective NOS II inhibitor, Mn(III)-tetrakis-(4-benzoic acid) porphyrin, a superoxide dismutase mimetic, 5,10,15,20-tetrakis-N-methyl-4′-pyridyl)-porphyrinato iron (III), a peroxynitrite decomposition catalyst, or l-cysteine, a peroxynitrite scavenger. We conclude that sGC/cGMP/PKG cascade and peroxynitrite formation may participate in Mev-induced phasic cardiovascular responses as signals downstream to NO generated respectively by NOS I and II in the RVLM.

Introduction

Whereas organophosphate poisons represent the oldest agents used in chemical warfare (McCauley et al., 2001), they are currently attracting renewed attentions because of their potential deployment by militias or terrorists (Lallement et al., 1999). The clinical presentations of organophosphate poisons are generally believed to entail over-stimulation of peripheral and central synapses by the accumulated acetylcholine that results from acetylcholinesterase inhibition (Tafuri and Roberts, 1987). Detailed cellular and molecular mechanisms of the cardiovascular responses to organophosphate poisons, particularly in relationship to central circulatory regulation, however, are relatively lacking.

Mevinphos (3-[dimethoxyphosphinyl-oxyl]-2-butenoic acid methyl ester; Mev) is the most commonly used organophosphate poison for suicidal purposes in Taiwan (Chuang et al., 1996). The US Environmental Protection Agency has placed it in Toxicity Category I, indicating the greatest degree of acute toxicity for oral, dermal and inhalation effects. Like other organophosphate insecticides, manifestations of Mev poisoning vary from salivation, muscle fasciculation to stupor, respiratory failure or death (Bardin and van Eeden, 1990). A prolonged corrected Q-T interval has been related to a higher rate of respiratory failure and mortality (Chuang et al., 1996). As an organophosphate of the P = O type, Mev exerts direct inhibition on acetylcholinesterase in the brain (Takahashi et al., 1991). Our laboratory has identified that the rostral ventrolateral medulla (RVLM), where premotor sympathetic neurons that are responsible for the maintenance of vasomotor tone are located (Ross et al., 1984), is a site of action for Mev (Chang et al., 2001, Yen et al., 2001, Yen et al., 2004). Based on results from power spectral analysis of systemic arterial pressure (SAP) signals, we previously (Chang et al., 2001, Yen et al., 2001) designated the two distinct phases of cardiovascular responses elicited by intravenous administration or microinjection of Mev into the RVLM as Phase I (sympathoexcitatory) and Phase II (sympathoinhibitory) Mev intoxication. We further showed (Chang et al., 2001, Chan et al., 2004b) that Mev intoxication may result from nitric oxide (NO) produced on activation of the M2 subtype of muscarinic receptors by the accumulated acetylcholine in the RVLM. Very recently (Chan et al., 2004b), we demonstrated that NO produced by NO synthase (NOS) I (neuronal NOS) and II (inducible NOS) in the RVLM plays respectively a sympathoexcitatory and sympathoinhibitory role in the phasic cardiovascular responses during Mev intoxication.

The soluble guanylyl cyclase(sGC)/cGMP/protein kinase G (PKG) cascade is a well-known intracellular signaling pathway for the physiological actions of NO (Arnold et al., 1977, Knowles et al., 1989). Mediation of the cytotoxic cardiovascular actions of NO by peroxynitrite, a potent reactive oxidant formed by the reaction between superoxide anion and NO was also reported (Beckman et al., 1990, Garcia-Estan et al., 2002). Of particular note is that peroxynitrite is primarily responsible for the fatal sympathoinhibition induced by overproduction of NO after activation of NOS II in the RVLM during experimental endotoxemia (Chan et al., 2002). It follows that sGC/cGMP/PKG cascade and peroxynitrite formation may participate in the phasic cardiovascular responses during Mev intoxication as signals downstream to NO generated respectively by NOS I and II in the RVLM. This hypothesis is validated in the present study, based on results obtained from pharmacological intervention, in conjunction with Western blot analysis and cardiovascular evaluations.

Section snippets

Methods

Adult male Sprague–Dawley rats (284–350 g, n = 256) purchased from the Experimental Animal Center, National Science Council, Taiwan, Republic of China were used. All experimental procedures were carried out in compliance with the guidelines of our institutional animal care committee.

Phasic cardiovascular responses to Mev

As we reported previously (Chang et al., 2001, Chan et al., 2004b), microinjection bilaterally of Mev (10 nmol) into the RVLM (cf. Fig. 3, Fig. 4, Fig. 5, Fig. 6) elicited a progressive hypotension that became significant 100 min postinjection and lasted the remainder of our 180-min observation period. This was accompanied by an insignificant change in HR (data not show). On-line power spectral analysis of SAP signals further revealed two distinct phases of Mev-induced cardiovascular responses.

Discussion

We reported previously that whereas all three NOS isoforms are expressed in the RVLM at mRNA or protein level, only NOS I and II are present in RVLM neurons and NOS III (endothelial NOS) is associated primarily with blood vessels (Chang et al., 2003). Furthermore, physiological regulation of sympathetic vasomotor outflow by the endogenous NO at the RVLM is determined by a balance between the tonically active NOS I and NOS II (Chan et al., 2001a), with minimal contribution from NOS III (Chang et

Acknowledgements

This study was supported by the Academic Excellence Program (89-B-FA08-1-4) to J.Y.H.C., S.H.H.C. and A.Y.W.C., the University Integration Program to S.H.H.C. and A.Y.W.C. from the Ministry of Education; and research grant NSC-93-2320-B-110-011 to A.Y.W.C. from the National Science Council, Taiwan, Republic of China. S.H.H.C. is National Chair Professor of Neuroscience appointed by the Ministry of Education, and Sun Yat-sen Research Chair Professor appointed by the National Sun Yat-sen

References (50)

  • S. Kagiyama et al.

    Cardiovascular effects of nitric oxide in the rostral ventrolateral medulla of rat

    Brain Research

    (1997)
  • J.K. Leach et al.

    Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation

    Journal of Biological Chemistry

    (2002)
  • R. Radi et al.

    Unraveling peroxynitrite formation in biological systems

    Free Radical Biology and Medicine

    (2001)
  • C. Szabo

    Physiological and pathophysiological roles of nitric oxide in the central nervous system

    Brain Research Bulletin

    (1996)
  • J. Tafuri et al.

    Organophosphate poisoning

    Annals of Emergency Medicine

    (1987)
  • H. Takahashi et al.

    Differences in the mode of lethality produced through intravenous and oral administration of organophosphorus insecticides in rats

    Fundamental and Applied Toxicology

    (1991)
  • A. van der Vliet et al.

    Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity

    Journal of Biological Chemistry

    (1997)
  • S.M. Wildhirt et al.

    S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction

    Biochemical and Biophysical Research Communications

    (1996)
  • W.P. Arnold et al.

    Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations

    Proceedings of the National Academy of Sciences USA

    (1977)
  • P.G. Bardin et al.

    Organophosphate poisoning: grading the severity and comparing treatment between atropine and glycopyrrolate

    Critical Care Medicine

    (1990)
  • J.S. Beckman et al.

    Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

    Proceedings of the National Academy of Sciences USA

    (1990)
  • J.S. Beckman et al.

    Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

    American Journal of Physiology

    (1996)
  • R.P. Brandes et al.

    Role of increased production of superoxide anion by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia

    Hypertension

    (1999)
  • C. Cerutti et al.

    Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis

    American Journal of Physiology

    (1994)
  • S.H.H. Chan et al.

    Differential engagements of glutamate and GABA receptors in cardiovascular actions of endogenous nNOS or iNOS at rostral ventrolateral medulla of rats

    British Journal of Pharmacology

    (2003)
  • Cited by (35)

    • Redox-active DJ-1 sustains brainstem cardiovascular regulation via maintenance of mitochondrial function during mevinphos intoxication

      2020, Neurochemistry International
      Citation Excerpt :

      Our laboratory demonstrated previously that fast-onset but short-lasting production of nitric oxide (NO) by nNOS in the RVLM, followed by activation of PKG signaling, is responsible for the augmentation of BLF power during Phase I mevinphos intoxication (Chan et al., 2005). On the other hand, formation of peroxynitrite by a reaction between superoxide and the slow-onset but long-lasting production of NO by inducible NO synthase (iNOS) in the RVLM is believed to be the culprits in the elicited loss of spontaneous baroreflex-mediated sympathetic vasomotor tone during Phase II (Chan et al., 2005; Tsai et al., 2018). The present study showed that immunoneutralization of DJ-1 significantly diminished the elevated BLF power during Phase I and shortened the duration of Phase I, followed by the reduced BLF power and moved to Phase II early.

    • Differential impacts of brain stem oxidative stress and nitrosative stress on sympathetic vasomotor tone

      2019, Pharmacology and Therapeutics
      Citation Excerpt :

      The sympathoexcitatory actions of endogenous NO generated by NOS I in the RVLM exhibit a pattern of fast onset and short duration (Chan et al., 2001, 2003). Together with the narratives presented in Section 5.3.3, it is reasonable to conclude that NO generated by NOS I elicits presynaptic facilitation of glutamate release through the sGC/cGMP/PKG cascade in RVLM in the elicitation of the pro-life phase of cardiovascular responses in experimental brain stem death (Chan et al., 2004, 2005; Huang et al., 2003; Li et al., 2005). This conclusion is in line with the reports that the NO/sGC/cGMP pathway facilitates glutamatergic neurotransmission (Fedele and Raiteri, 1999; Martins-Pinge et al., 1999; Morimoto et al., 2000) by acting presynaptically on N-type Ca2+ channels (Huang et al. 2003).

    • PTEN, a negative regulator of PI3K/Akt signaling, sustains brain stem cardiovascular regulation during mevinphos intoxication

      2017, Neuropharmacology
      Citation Excerpt :

      Temporal changes in pulsatile AP, mean AP (MAP), HR and power density of the BLF component were displayed continuously before and after the administration of mevinphos. We routinely collected tissue samples (Chan et al., 2005a; Tsai et al., 2014, 2015) at the peak of Phase I or Phase II mevinphos intoxication (mevinphos group; designated MI or MII in figures), or 30 or 180 min after microinjection of aCSF (vehicle-control group; designated AI or AII in figures). Medullary tissues collected from anesthetized animals but without treatment served as the sham-controls.

    • Upregulation of FLJ10540, a PI3K-association protein, in rostral ventrolateral medulla impairs brain stem cardiovascular regulation during mevinphos intoxication

      2015, Biochemical Pharmacology
      Citation Excerpt :

      To avoid the confounding effects of drug interactions, each animal received mevinphos or aCSF, plus FLJ10540 antiserum or NRS. We routinely collected tissue samples [14–16] during the peak of Phases I or II (mevinphos group), or 30 or 180 min after microinjection of aCSF or NRS. Medullary tissues collected from anesthetized animals but without treatment served as the sham-controls.

    View all citing articles on Scopus
    View full text